دورية أكاديمية

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure

التفاصيل البيبلوغرافية
العنوان: Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
المؤلفون: E. V. Kovalenko, M. V. Lozhkina, G. G. Arabidze, V. G. Kryakushkin
المصدر: Российский кардиологический журнал, Vol 26, Iss 1 (2021)
بيانات النشر: «FIRMA «SILICEA» LLC, 2021.
سنة النشر: 2021
المجموعة: LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية: heart failure, type 2 diabetes, sodium-glucose co-transporter-2 inhibitor, empagliflozin, dapagliflozin, canagliflozin, ertugliflozin, sotagliflozin, Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: The article analyzes the new results of randomized clinical trials on the use of sodium-glucose co-transporter-2 inhibitors in patients with cardiovascular diseases, heart failure with and without type 2 diabetes. The data of the latest studies (EMPEROR reduced, VERTIS CV, SOLOIST-WHF, SCORED) are presented in more detail.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: Russian
تدمد: 1560-4071
2618-7620
Relation: https://russjcardiol.elpub.ru/jour/article/view/4235; https://doaj.org/toc/1560-4071; https://doaj.org/toc/2618-7620
DOI: 10.15829/1560-4071-2021-4235
URL الوصول: https://doaj.org/article/5390d165b7604afb80f353006d00b7ba
رقم الأكسشن: edsdoj.5390d165b7604afb80f353006d00b7ba
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:15604071
26187620
DOI:10.15829/1560-4071-2021-4235